Reaction
Spleen Atrophy reporting signals
As of the last recalculation, Spleen Atrophy appears in 59 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ACALABRUTINIB (PRR 350.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Acalabrutinib | 10 | 350.3 | 350.6 |
| Bendamustine Hcl | 9 | 241.4 | 241.6 |
| Obinutuzumab | 9 | 227.6 | 227.7 |